Formulation |
Lyophilized from a 0.2?m filtered concentrated solution in PBS, pH 7.4 containing 5% trehalose. |
Solubility |
It is recommended to reconstitute the lyophilized IL-13 in sterile 18M-cm H2O not less than 100ug/ml, which can then be further diluted to other aqueous solutions. |
Purity |
Greater than 97.0% as determined by SDS-PAGE and HPLC analyses. |
Description |
IL 13 Rhesus Macaque Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 114 amino acids and having a molecular mass of 12.6kDa.The IL 13 Rhesus Macaque is purified by proprietary chromatographic techniques. |
Protein Background |
IL13 is an immunoregulatory cytokine produced primarily by activated Th2 cells. IL-13 is involved in several stages of B-cell maturation and differentiation. It up-regulates CD23 and MHC class II expression, and promotes IgE isotype switching of B cells. This cytokine down-regulates macrophage activity, thereby inhibits the production of pro-inflammatory cytokines and chemokines. This cytokine is found to be critical to the pathogenesis of allergen-induced asthma but operates through mechanisms independent of IgE and eosinophils. This gene, IL3, IL5, IL4, and CSF2 form a cytokine gene cluster on chromosome 5q, with this gene particularly close to IL4. |
Expression host |
Escherichia Coli. |
Synonyms |
NC30, ALRH, BHR1, P600, IL-13, MGC116786, MGC116788, MGC116789. |
Reagent Appearance |
Sterile Filtered White lyophilized (freeze-dried) powder. |
Stability |
Lyophilized IL-13 although stable at room temperature for 3 weeks, should be stored desiccated below -18°C. Upon reconstitution IL-13 should be stored at 4°C between 2-7 days and for future use below -18°C.Please prevent freeze-thaw cycles. |
Amino acid sequence |
SPSPVPRSTA LKELIEELVN ITQNQKAPLC NGSMVWSINL TAGVYCAALE SLINVSGCSA IEKTQRMLNG FCPHKVSAGQ FSSLRVRDTK IEVAQFVKDL LVHLKKLFRE GRFN |
Biological Activity |
The ED50 as determined by the dose-dependent proliferation of TF-1 cells was 11,000,000 units/mg. |